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Abstract
Sodium is the main extracellular cation. In recent years, many mechanisms that have been involved in the regulation 
of sodium metabolism have been described, such as interstitial tissue and glycosaminoglycans, Th17 lymphocytes and 
interleukin 17, epithelial sodium channel, glycocalyx and proprotein converting enzyme subtilisin/kexin type 6. Com-
plexity of homeostasis mechanisms sodium makes it an interest in modern pharmacology. The described mechanisms 
somewhat explain the sodium sensitivity phenomenon occurring in a significant proportion of patients with arterial 
hypertension.
Processed foods are the main source of salt in the diet. The food processing process is associated with a significant 
increase in the salt content of these products. Excessive salt intake in the diet is observed in most countries of the 
world. The relationship between excessive salt intake in the diet and the occurrence of diseases such as hypertension, 
stroke, stomach cancer, left ventricular hypertrophy, urolithiasis and others has been the subject of numerous studies. 
Numerous benefits of reducing salt in the diet have been demonstrated.
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Sodium metabolism in the human body
Sodium is the main extracellular cation in the human body. 
Its total body content is approx. 4200 mmol (60 mmol/kg 
body weight). As much as 91% of total sodium in the 
human body is found in the extracellular space, where 
it reaches a concentration of 135–145 mmol/L. The 
intracellular space contains 9% of total sodium in the 
human body, and its concentration is 10–20 mmol/L 
[1, 2]. Nearly 1/3 of total sodium in the body (approx. 
20 mmol/kg body weight) is poorly exchangeable or not 
exchangeable, and it is mostly located in the bones. The 
remaining amount of sodium (approx. 40 mmol/kg body 
weight) is mainly located in the extracellular space, and 
it is well exchangeable [1–3].
Sodium supplied with food is mostly absorbed in the 
middle and further part of the small intestine. In case of 
preserved sodium homeostasis, as much as 95% of sod ium 
ingested with food is excreted through the kidneys, 4.5% 
through the digestive tract and 0.5% through the skin [2]. 
A number of mechanisms are involved in the regulation of 
sodium metabolism. The most important ones include: re-
nin–angiotensin–aldosterone system, reduction of sodium 
charge reaching the macula densa in the distal convoluted 
tubule of the nephron, natriuretic peptide system, pressure 
natriuresis as well as hypercalcaemia and hypokalaemia [4].
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Regulation of sodium metabolism  
— selected mechanisms
Subcutaneous connective tissue  
— glycosaminoglycans
For many years it has been believed that the sodium 
concentration in the extracellular extravascular fluid 
compartment (i.e. interstitial fluid compartment) does not 
differ much from the sodium concentration in the plasma. 
Small differences in the sodium concentration between 
these compartments were explained by significantly higher 
concentrations of proteins in the blood plasma than in the 
interstitial fluid compartment, which was justified in the 
Gibbs-Donnan effect [5].
An important role of subcutaneous tissue in the regu-
lation of sodium metabolism has been described in recent 
years [6]. In the interstitial fluid compartment, especially 
in the subcutaneous tissue, there are a lot of glycosamino-
glycans (GAGs) forming proteoglycans of the connective 
tissue. GAGs are involved in the storage of sodium in the 
subcutaneous tissue (Figure 1) [6,7]. Sodium accumu-
lated in the interstitial tissue is inactive osmotically, as 
a result of which it does not affect the water retention by 
the kidneys [7].
An increased sodium concentration in the intersti-
tial tissue stimulates the inflow of macrophages (MPS, 
mononuclear phagocyte phagocyte system cells) into 
this space. Under the influence of local hypernatraemia, 
these cells activate the expression of the tonicity enhanc-
er binding protein (TonEBP) gene, which is a transcription 
factor [7, 8]. The protein stimulates the expression of 
the vascular endothelial growth factor C gene (VEGF-C) 
and increases its secretion by MPSs. The main effects of 
VEGF-C are: activation of lymphangiogenesis, angiogene-
sis, sodium clearance from the interstitial tissue through 
the stimulation of sodium bonding by GAGs and genera-
tion of nitric oxide. The VEGF-C gene performs these func-
tions through two membrane receptors. The activation of 
Figure 1. Involvement of the interstitial tissue in the regulation of sodium metabolism (based on [10]); TonEBP — tonicity enhancer binding 
protein; VEGF-C — vascular endothelial growth factor C; eNOS — endothelial nitric oxide synthase
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vascular endothelial growth factor receptor 3 (VEGFR-3) 
leads to the above-mentioned lymphangiogenesis and 
angiogenesis and to GAGs being transported with lymph. 
The activation of the vascular endothelial growth factor 
receptor 2 (VEGFR-2 receptor) stimulates vascular en-
dothelial cells to the above-mentioned synthesis of nitric 
oxide (the VEGF-C gene activates the endothelial nitric 
oxide synthase). The bonding between sodium and GAGs 
leads to their osmotic immobilisation [6, 9, 10]. It was 
demonstrated that during a diet rich in sodium hyperten-
sion was more common in animals in which macrophages 
were destroyed as a result of the administration of lipos-
omes with clodronate [9].
The above-mentioned phenomena related to the ac-
cumulation of sodium ions by GAGs in the subcutaneous 
tissue and the involvement of the immune system in this 
process were also demonstrated in humans. Selvarajah et 
al. [11] showed that the skin can buffer sodium provided 
in the diet, reducing the haemodynamic effects of an in-
creased sodium content in the body. This effect was more 
visible in men, which indicates that gender affects the abil-
ity of the subcutaneous tissue to immobilise sodium [11]. 
The method used to locate osmotically inactive sodium is 
23Na+-MRI [12].
Taking the above-mentioned data into account, it can 
be concluded that sodium can be accumulated not only in 
the osmotically active form, increasing the volume of ex-
tracellular fluid (according to the Guyton’s hypothesis), but 
also in the osmotically inactive form associated with GAGs. 
Moreover, the immune system also has a significant effect 
on the regulation of sodium metabolism through the forma-
tion of new lymphatic vessels, thanks to which GAGs are 
extracted from the skin along with sodium [10].
It is also worth noting that the above mechanisms 
that form the signalling pathway TonEBP-VEGF-C-VEGFC- 
-R-NO-lymphangiogenesis and angiogenesis may explain 
different levels of sensitivity to sodium supplied with diet, 
expressed by changes in blood pressure (sodium sensi-
tivity). Sodium sensitivity is defined as a change in blood 
pressure of at least 10 mm Hg in response to a 4-hour infu-
sion of 2,000 mL of NaCl compared to the blood pressure 
measured after following a low-sodium diet (10–20 mmol 
NaCl/day) for several days [13]. Sodium sensitivity occurs 
in 30–50% of patients with hypertension and 20–30% of 
patients with normal blood pressure, which indicates that 
it is a significant clinical problem [14]. In conclusion, it 
can be stated that sodium-dependent blood pressure (so-
dium-dependent hypertension) may result from reduced 
interstitial volume in the scope of the osmotic inactivation 
of sodium (as well as an impaired normal immobilisation 
of sodium in the interstitium), whereas sodium-independ-
ent hypertension may be the result of increased volume 
in the scope of the inactivation of sodium ions by the in-
terstitial tissue [10].
There is also another practical conclusion to be drawn 
from this discussion. It is not possible to predict an increase 
in natraemia in patients with hyponatraemia during correc-
tive treatment based on the knowledge of the size of fluid 
compartments in the body. In such patients, the ability of 
the interstitial tissue to immobilise sodium may vary. There-
fore, to avoid the phenomenon of overcorrection, the most 
severe complication of which is pontine demyelination syn-
drome, it is necessary to determine natraemia as often as 
possible during corrective treatment [3].
Th17 lymphocytes and interleukin 17
The results of some tests on animals indicate that Th17 
lymphocytes, which produce interleukin 17 (IL-17), are 
attracted to the interstitial tissue by GAGs combined with 
sodium ions. Interleukin 17 has hypertensive properties 
by increasing the stiffness of the vascular endothelium 
[15, 16].
Increased salt intake in the diet leads to an increase 
in the number of Th17 lymphocytes and reduces the num-
ber of Lactobacillus murinus in the human gut microbiota. 
Based on the studies, it was demonstrated that the admin-
istration of probiotics with Lactobacillus murinus reduces 
the occurrence of sodium-dependent increase in blood 
pressure and in the number of Th17 lymphocytes [17]. An 
excessive amount of salt leads to a reduction in the number 
of Lactobacillus murinus, as a result of which the amount 
of indole compounds decreases. A reduced concentration 
of these compounds leads to the stimulation of the differ-
entiation of T lymphocytes into Th17 lymphocytes. These 
lymphocytes secrete the above-mentioned IL-17, which, on 
the one hand, intensifies the reabsorption of sodium from 
the intestines and, on the other hand, damages the vas-
cular endothelium (impaired vasodilatory properties). Both 
mechanisms increase blood pressure [18]. It was shown 
that an increased amount of salt in the diet can also in-
crease the number of Th17 lymphocytes by activating the 
antigen-presenting cells (APC). As a result of the stimulation 
of APC, IL-23, IL-6 and IL-1 are secreted, which stimulate 
T lymphocytes to secrete IL-17 and other proinflammatory 
cytokines. The above-mentioned phenomena lead to the 
inflammation of the kidneys and blood vessels, which in 
turn contributes to the development of hypertension [19].
The study results indicate that Th17 lymphocytes, in-
terleukin 17 and gut microbiota, the composition of which 
depends on the diet, has a significant impact on the regu-
lation of sodium metabolism [20].
Epithelial sodium channel (ENaC)  
and glycocalyx
Increased sodium intake in the diet leads to the activation 
of the sympathetic nervous system, which results, for 
instance, in the activation of the renin–angiotensin–al-
dosterone system [21]. By affecting the mineralocorticoid 
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receptor (MR), aldosterone increases the gene expression 
for the epithelial sodium channel (ENaC) [22]. Increased 
sodium intake in the diet can also increase the MR activity 
by increasing the activity of protein Rac1 (MR activity mod-
ulator). It has been demonstrated that an increased activity 
of Rac1 may lead to the development of sodium-dependent 
hypertension [23]. An increase in the amount of ENaC on 
the surface of vascular endothelial cells increases the 
sensitivity of these cells to shear stress exerted by blood-
stream. The ENaC channel combines with globular actin 
(G-actin) leading to its polymerisation and the creation of 
filamentous actin (F-actin). Filamentous actin increases 
the stiffness of the shell of vascular endothelial cells, 
resulting in an increase in the total peripheral resistance 
(TPR), which is an important determinant of blood pressure 
(Figure 2) [24].
The more ENaC is found in the membrane of vascular 
endothelial cells, the more sensitive to shear stress and 
the stiffer these cells are. An additional factor stimulating 
the change in actin conformation is the change in glyco-
calyx conformation (decrease in its height and increase 
in the stiffness) of vascular endothelial cells. The factors 
changing the glycocalyx conformation are shear stress and 
direct toxic effects of sodium (already in the concentration 
found in the plasma > 139 mmol/L, i.e. within the normal 
range) [25, 26]. Glycocalyx and ENaC are therefore shear 
stress sensors (Figure 2). Moreover, an increase in the in-
tracellular concentration of sodium ions with a simulta-
neous decrease in the concentration of potassium ions 
is another factor activating the polymerisation of G actin 
into F actin (this is an important mechanism because in 
Poland people consume an excessive amount of salt and 
a low amount of potassium in their diet) (Figure 2). An in-
creased stiffness of the shell of endothelial cells reduces 
the activity of nitric oxide synthase and reduces the sen-
sitivity of these cells to NO [27]. In contrast to sodium, an 
increased serum concentration of potassium reduces the 
stiffness of endothelial cells and increases the release of 
NO [28, 29]. According to Oberleithner et al. [24]: 1) there 
is a negative correlation between the “stiffness” of vascular 
endothelial cells and the activity of endothelial nitric oxide 
synthase; 2) an increase in the concentration of sodium in 
the plasma significantly increases the stiffness of vascu-
lar endothelial cells (in the presence of aldosterone and 
ENaC); 3) an increase in potassium in the plasma reduces 
the stiffness of vascular endothelial cells and increases the 
activity of endothelial nitric oxide synthase only in the case 
of low sodium concentrations in the plasma.
In conclusion, it can be stated that an increased so-
dium intake in the diet has a negative effect on the vas-
cular endothelial function by stimulating the sympathetic 
nervous system and the renin–angiotensin–aldosterone 
system, and by changing the glycocalyx conformation. All 
these processes lead to an increased stiffness of vascular 
endothelial cells, which directly results in increased blood 
pressure. It should be emphasised that increased sodium 
intake directly impairs normal endothelial function, which 
in turn results in increased blood pressure in the mecha-
nism independent of the volume status.
Proprotein convertase subtilisin/kexin  
type 6 (PCSK6)
Proprotein convertase subtilisin/kexin type 6 (PCSK6) is 
a serine protease involved in the activation of corrin. Corrin 
Figure 2. Effects of increased sodium intake in the diet on vascular endothelial cells; Na+ — sodium; ENaC — epithelial sodium channel; 
K+ — potassium; MR — mineralocorticoid receptor
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is an enzyme necessary for the formation of a biologically 
active atrial natriuretic peptide (ANP). The PCSK6 gene 
mutation leads to sodium-dependent hypertension. Exper-
imental studies have shown that the use of benzamidine 
(serine protease inhibitor) led to the inhibition of corrin 
activation. The PCSK6 gene mutation leads to a decrease 
in the secretion of ANP, which in consequence impairs 
the excretion of excessive sodium from the body and in-
creases natraemia. Increased natraemia in turn leads to 
an increase in the volume status and blood pressure [30].
The above-mentioned mechanisms regulating sodium 
metabolism, which have been described relatively recently, 
show us the complexity of sodium homeostasis. It can be 
expected that the above-mentioned elements of the regu-
lation of sodium metabolism will be the subject of further 
experimental and clinical studies and that they may become 
be a new possible target for drug therapy of hypertension 
and other cardiovascular diseases in the future.
Sources of sodium in the diet
Sodium is a natural ingredient of food of animal and plant 
origin. It is used in the form of table salt (NaCl) during 
seasoning and adding salt to meals. Moreover, it is an 
important ingredient added to processed food to extend 
its shelf-life [31].
According to the European Society of Cardiology (ESC), 
the sources of salt in everyday diet include processed 
products (72%), salt added during cooking (20%) and salt 
contained in water and drugs (8%) [32]. It is worth noting 
that we may directly affect only 20% of all salt sources in 
our diet [32].
According to other authors, processed food products 
are the source of not 72% but 85% of the daily amount of 
salt in the diet [31, 33].
A high salt content is typical of fast-food products. A typi-
cal fast-food lunch set consisting of a hamburger, chips and 
sauce (usually ketchup) contains 4.5 g of salt, which is as 
much as 90% of the daily recommended intake (DRI). Kebab, 
which is another popular fast-food product, contains about 
4.0 to 8.4 g of salt, while pizza 7.0 to 12.8 g of NaCl. It is also 
worth mentioning the so-called instant soups which contain 
even up to 4.1 g of salt [34–37]. One slice of white or whole-
grain bread contains about 0.5 g of NaCl [38].
The Institute of Food and Nutrition in Warsaw has pre-
pared a report comparing salt content in fresh products 
and their processed equivalents (Figure 3).
As can be seen in Figure 3, The processing of food in-
volves a significant increase in its salt content [31, 33].
Salt consumption in Poland and Europe
Studies carried out by Eaton and Konner have shown that 
the ancestors of man consumed food with a salt content 
not exceeding 1 g/day. These observations indicate that 
man is evolutionarily adapted to a diet considered now to 
be low sodium [39, 40].
Currently, the average consumption of sodium in the 
world is about 3.95 g/day, i.e. about 10 g of NaCl (1 g of 
NaCl contains 0.4 g of sodium). Salt consumption varies 
in European countries (Figure 4) [41].
As far as the consumption of salt in Poland, especially 
by men, is concerned, our country ranks high compared to 
other EU countries [41].
Figure 3. Salt content in selected fresh and processed products. The difference in salt content in products (g/100g of the product) is given 
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In Central and Eastern Asia and Western Europe, the 
average sodium intake is > 4.2 g/day (> 10.5 g NaCl/day). 
In North America, Western Europe as well as Australia 
and New Zealand, the average sodium intake varies be-
tween 3.4 to 3.8 g/day (8.5 to 9.5 g NaCl/day), whereas 
in Sub-Saharan Africa and Central America, it is < 3.3 g/ 
/day (< 8.25 g NaCl/day) [42].
Salt consumption  
and cardiovascular diseases
According to Mozzaffarian et al., 1.65 million deaths from 
cardiovascular diseases per year all over the world are 
associated with excessive sodium consumption: 61.9% 
of these deaths occurred in men and 38.1% in women. 
These deaths represented almost 1 in 10 deaths from 
cardiovascular diseases (9.5%) [43].
Arterial hypertension
The risk of cardiovascular disease increases with an increase 
in blood pressure. Evidence derived from many different 
studies confirms a direct correlation between salt consump-
tion and blood pressure. The INTERSALT Study (International 
Study of Electrolyte Excretion and Blood Pressure) was one 
of the first observational studies on salt intake and blood 
pressure. The study included 10,074 women and men from 
32 countries. Sodium excretion was measured based on the 
24-hour urine collection. A clear correlation was observed 
between daily sodium intake and systolic blood pressure 
[44]. Taking the above results into account, it was decided to 
check whether limited sodium intake in the diet would result 
in the decrease in blood pressure. The DASH-Sodium Study 
(Dietary Approaches to Stop Hypertension - Sodium Study), 
conducted in the United States on a group of 412 patients 
with prehypertension or stage-1 hypertension, was the flag-
ship study evaluating this phenomenon. The subjects were 
randomly assigned to follow the DASH diet, i.e. the so-called 
healthy diet (low in salt), and the typical American diet (rich 
in salt). It was observed that the systolic blood pressure in 
patients with both prehypertension and stage-1 hypertension 
decreased by 11.5 mm Hg on average, which corresponds 
to the administration of one antihypertensive drug [45].
The meta-analysis of 126 intervention studies with the 
participation of patients with hypertension, carried out by 
Graudal et al. [46] showed that limited salt intake in the 
diet leads to a decrease in systolic and diastolic blood 
pressure. It should be mentioned that the race of the 
subjects did not affect the observed effect [46]. It is also 
worth pointing out that limited salt intake in the diet may 
help to control resistant hypertension [47]. The TONE (Trial 
of Nonpharmacologic Interventions in the Elderly) study 
assessed the effect of limiting the dietary sodium intake 
(< 80 mmol/day) in hypertensive patients treated with 
a single antihypertensive drug. After 3 months an attempt 
was made to stop antihypertensive treatment. The attempt 
was successful for 30% of the patients [48].
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In conclusion, it should be stated that any limitation of 
table salt intake in the diet has a beneficial effect on both 
the risk of developing, and the treatment of, hypertension.
Other cardiovascular diseases
An increase of 5 g/day in salt intake involves a 17-percent 
higher risk of cardiovascular disease and a 23-percent 
higher risk of stroke. Finland has been striving to reduce the 
intake of salt in the diet since the 1970s. For more than 30 
years of taking preventive action, Finland has managed to 
reduce its salt intake by one third (6 g/day). Systolic blood 
pressure decreased by over 10 mm Hg on average and 
mortality from stroke and ischaemic heart disease fell by 
75–80%, whereas life expectancy increased by 5–6 years 
[49, 50]. Similar preventive measures have also been taken 
in Japan. Over the decade, salt intake in this country has 
fallen from 13.5 g/day to 12.1 g/day. It was associated 
with a significant decrease in stroke mortality [49, 50].
Left ventricular hypertrophy is an important risk factor 
for premature failure of this organ. Regardless of blood 
pressure, salt intake is a risk factor for left ventricular hy-
pertrophy. It has been shown that limited salt intake in the 
diet leads to the regression of left ventricular hypertrophy 
[51]. Moreover, limited dietary salt intake seems to nor-
malise glomerular hyperfiltration, which often precedes the 
development of hypertension, observed in sodium-sensi-
tive individuals [52].
Excessive salt intake is also a risk factor for other dise-
ases (Table 1).
Recommendations for limiting  
salt intake in the diet
In the guidelines published in 2018, the Polish Society of 
Hypertension recommends to limit the intake of table salt 
from the usual amount of 9–12 g of NaCl to less than 5 g 
of NaCl (2 g Na)/day. This recommendation concerns both 
patients with hypertension and those who want to lead 
a healthy lifestyle [53]. It is worth mentioning that 5 g of 
table salt is the equivalent of one teaspoon. Salt intake in 
Poland and Europe significantly exceeds the recommended 
amount of 5 g/day (Figure 4 — green line) [41].
The Institute of Food and Nutrition in Warsaw symboli-
cally crosses out the salt shaker on the Pyramid of Healthy 
Nutrition and Physical Activity and proposes several ways 
to reduce the intake of salt in the diet, such as: limiting the 
amount of salt added during meal preparation or, if neces-
sary, adding salt at the end of cooking, using fresh or dried 
herbs instead of salt, using potassium sodium salt (a mix-
ture of KCl and NaCl) and choosing products with a lower 
salt content (DRI, daily recommended intake — %) [54].
A study carried out on the veterans living in Taiwan 
(2.5-year observation) showed that a 17% reduction in the 
use of NaCl along with a 76% increase in the intake of KCl 
in the diet reduced the risk of death from cardiovascular 
dise ases by 40% [55].
Conclusion
The article presents the elements of the regulation of 
sodium metabolism that have been discovered only re-
cently and that are of interest to modern pharmacology; 
they show how complex maintaining the homeostasis of 
this ion in the body is. These mechanisms also explain, 
in a way, the phenomenon of sodium sensitivity occurring 
in a considerable number of people. As shown by the 
research, eating habits associated with the consumption 
of table salt lead to the development of hypertension, 
cardiovascular and many other diseases resulting in 
many premature deaths. The consumption of salt in 
Poland still significantly exceeds 5 g recommended by 
the Polish Society of Hypertension. Most of salt in an 
average diet comes from processed foods (72–85%). The 
Institute of Food and Nutrition in Warsaw recommends 
several ways that will help people limit the intake of 
salt in the diet. Special attention is drawn to the use of 
potassium sodium salt.
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Streszczenie
Sód jest głównym kationem zewnątrzkomórkowym. W ostatnich latach opisano wiele mechanizmów biorących udział 
w regulacji gospodarki sodowej, takich jak: tkanka śródmiąższowa i glikozaminoglikany, limfocyty Th17 i interleukina 17, 
nabłonkowy kanał sodowy, glikokaliks oraz proproteinowa konwertaza subtyliziny/kexiny typu 6. Złożoność mecha-
nizmów homeostazy gospodarki sodowej sprawia, że budzi ona zainteresowanie nowoczesnej farmakologii. Opisane 
mechanizmy poniekąd tłumaczą zjawisko sodowrażliwości występujące u znacznej części chorych z nadciśnieniem 
tętniczym.
Głównym źródłem soli w diecie są pokarmy przetworzone. Proces przetwarzania pokarmów wiąże się z znacznym wzro-
stem zawartości soli w tych produktach. Nadmierne spożycie soli w diecie obserwuje się w większości krajów świata. 
Związek między nadmiernym spożyciem soli w diecie a występowaniem chorób, takich jak nadciśnienie tętnicze, udar 
mózgu, rak żołądka, przerost lewej komory serca, kamica moczowa i inne, był przedmiotem licznych badań. Wykazano 
liczne korzyści płynące z ograniczenia soli w diecie.
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